{
    "title": "Kite's shares fly high after cancer drug clears main study goal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4268376/Kites-shares-fly-high-cancer-drug-clears-main-study-goal.html",
    "date": "2017-02-28",
    "keywords": [
        "therapy",
        "inc",
        "tcell",
        "juno",
        "analyst",
        "drug",
        "tuesday",
        "car",
        "cancer",
        "cell",
        "trial",
        "approval",
        "end",
        "cart",
        "mukhopadhyayfeb",
        "immune",
        "system",
        "goal",
        "percent",
        "component",
        "number",
        "novartis",
        "ag",
        "bluebird",
        "bio",
        "body",
        "type",
        "blood",
        "night",
        "pain",
        "loss",
        "data",
        "midstage",
        "september",
        "company",
        "analysis",
        "eventsdata",
        "riskbenefit",
        "efficacy",
        "year",
        "capital",
        "yee",
        "notekite",
        "marketing",
        "application",
        "biren",
        "amin",
        "food",
        "administration",
        "partnership",
        "celgene",
        "remission",
        "myeloma",
        "side",
        "studybut",
        "november",
        "leukemia",
        "brain",
        "therapywe",
        "category",
        "ability",
        "michael",
        "schmidt",
        "note",
        "reporting",
        "mukhopadhyay",
        "bengaluru",
        "editing",
        "dsouza",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}